Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 40Recruiting 15Active not recruiting 15Terminated 8Withdrawn 5Unknown 5No longer available 2Approved for marketing 2Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Specimen Handling 5Nivolumab 3Biopsy 3Magnetic Resonance Spectroscopy 2Docetaxel 2talazoparib 1romidepsin 1pembrolizumab 1olaparib 1imisopasem manganese 1gallium 68 PSMA-11 1durvalumab 1balstilimab 1aldesleukin 1abivertinib 1abiraterone 1abarelix 1Watchful Waiting 1Standard of Care 1Radiosurgery 1Practice Guidelines as Topic 1Palliative Care 1Paclitaxel 1Observation 1N-acetylcochinol-O-phosphate 1Mental Status and Dementia Tests 1Menogaril 1Magnetic Resonance Imaging 1Ketones 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × gallium 68 PSMA-11 × Genitourinary × Clear all
NCT06355843 2024-04-09

Clinical Applications of Integrated PET/MR and PET/CT in the Diagnosis and Treatment of Prostate Cancer.

The First Affiliated Hospital of Anhui Medical University

Phase NA Suspended
50 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡